Skip to main content
Saturday
June 14, 2025
Sign In
Subscribe
Latest
Economy
Banking
Stocks
Industry
Analysis
Bazaar
RMG
Corporates
Aviation
Videos
TBS Today
TBS Stories
TBS World
News of the day
TBS Programs
Podcast
Editor's Pick
World+Biz
Features
Panorama
The Big Picture
Pursuit
Habitat
Thoughts
Splash
Mode
Tech
Explorer
Brands
In Focus
Book Review
Earth
Food
Luxury
Wheels
More
Sports
TBS Graduates
Bangladesh
Supplement
Infograph
Archive
Gallery
Long Read
Interviews
Offbeat
Magazine
Climate Change
Health
Cartoons
বাংলা
SATURDAY,
JUNE 14, 2025
Serum Institute of India (SII)
South Asia
India develops its first cervical cancer vaccine
Global Economy
Indian vaccine giant Serum plans African plant in global expansion
Coronavirus chronicle
Omicron-specific booster shot possible: SII CEO Adar Poonawalla
Coronavirus chronicle
Serum Institute to resume supply of Covishield to Covax: Reports
South Asia
India rules out reducing gap between Covishield doses
Coronavirus chronicle
India allows Serum Institute to enrol 7-11 year olds in Novavax Covid-19 vaccine trial
Coronavirus chronicle
India's Serum Institute to invest $68 million in UK vaccine maker Oxford Biomedica
Covid-19 in Bangladesh
Bangladesh to get vaccines from India soon: Doraiswami
Bangladesh
SII must return money if they fail to deliver vaccines: Health minister
World+Biz
Serum Institute of India to manufacture Sputnik V starting September
Coronavirus chronicle
India raises Covid vaccine production amid sharp dip in cases
Coronavirus chronicle
SII seeks EU travel approval for its Covishield vaccine
Coronavirus chronicle
SII to introduce Novavax vaccine in India by September
Show More